M.M. Balp

696 total citations
24 papers, 112 citations indexed

About

M.M. Balp is a scholar working on Rheumatology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, M.M. Balp has authored 24 papers receiving a total of 112 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Rheumatology, 10 papers in Pathology and Forensic Medicine and 8 papers in Dermatology. Recurrent topics in M.M. Balp's work include Urticaria and Related Conditions (16 papers), Autoimmune Bullous Skin Diseases (9 papers) and Dermatology and Skin Diseases (6 papers). M.M. Balp is often cited by papers focused on Urticaria and Related Conditions (16 papers), Autoimmune Bullous Skin Diseases (9 papers) and Dermatology and Skin Diseases (6 papers). M.M. Balp collaborates with scholars based in Switzerland, United States and United Kingdom. M.M. Balp's co-authors include Sam Khalil, Marta Ferrer, Ana M. Giménez‐Arnau, Nico Janssens, Marcus Maurer, Evgeniya Antonova, A.Y. Finlay, James L. Zazzali, Allen P. Kaplan and Lisa A. Beck and has published in prestigious journals such as Value in Health, Journal of the European Academy of Dermatology and Venereology and Annals of Allergy Asthma & Immunology.

In The Last Decade

M.M. Balp

21 papers receiving 111 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.M. Balp Switzerland 5 85 54 51 22 17 24 112
Christof Pohl Germany 3 73 0.9× 22 0.4× 11 0.2× 5 0.2× 5 0.3× 4 90
Maximiliano Gómez Argentina 6 79 0.9× 35 0.6× 35 0.7× 15 0.7× 38 2.2× 11 155
Warner Carr United States 8 37 0.4× 18 0.3× 17 0.3× 24 1.1× 12 0.7× 21 145
María Jesús Castillo Spain 3 27 0.3× 59 1.1× 7 0.1× 30 1.4× 27 1.6× 5 89
Anushya Jeyabalan United States 5 16 0.2× 25 0.5× 16 0.3× 12 0.5× 2 0.1× 19 89
Neil L. Kao United States 6 14 0.2× 18 0.3× 10 0.2× 8 0.4× 5 0.3× 10 88
Elaine Smith United Kingdom 5 37 0.4× 7 0.1× 15 0.3× 14 0.6× 5 0.3× 7 99
Sílvia Papasidero Argentina 5 73 0.9× 13 0.2× 13 0.3× 21 1.0× 17 87
Domenico Olivo Italy 5 45 0.5× 9 0.2× 7 0.1× 9 0.4× 3 0.2× 8 76
Jolanta Gąsior Poland 6 53 0.6× 16 0.3× 7 0.1× 7 0.3× 3 0.2× 8 80

Countries citing papers authored by M.M. Balp

Since Specialization
Citations

This map shows the geographic impact of M.M. Balp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.M. Balp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.M. Balp more than expected).

Fields of papers citing papers by M.M. Balp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.M. Balp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.M. Balp. The network helps show where M.M. Balp may publish in the future.

Co-authorship network of co-authors of M.M. Balp

This figure shows the co-authorship network connecting the top 25 collaborators of M.M. Balp. A scholar is included among the top collaborators of M.M. Balp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.M. Balp. M.M. Balp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weller, Karsten, et al.. (2025). Urticaria Voices: Real-World Experience of Patients Living with Chronic Spontaneous Urticaria. Dermatology and Therapy. 15(3). 747–761. 4 indexed citations
2.
Soong, Weily, et al.. (2025). Clinical profile, prevalence, and burden of chronic spontaneous urticaria in the United States. World Allergy Organization Journal. 18(8). 101081–101081.
3.
4.
Bernstein, Jonine L., et al.. (2023). THE URTICARIA VOICES STUDY: ANTIHISTAMINE TREATMENT PATTERNS AND PATIENT REPORTED CONTROL IN CHRONIC SPONTANEOUS URTICARIA. Annals of Allergy Asthma & Immunology. 131(5). S10–S11. 2 indexed citations
5.
Ferrer, Marta, et al.. (2018). Predicting Chronic Spontaneous Urticaria Symptom Return After Omalizumab Treatment Discontinuation: Exploratory Analysis. The Journal of Allergy and Clinical Immunology In Practice. 6(4). 1191–1197.e5. 35 indexed citations
6.
7.
Pedrosa, Marcos, et al.. (2018). Global Prevalence of Nonalcoholic Steatohepatitis (NASH): Findings from a Targeted Literature Review. Value in Health. 21. S82–S82. 7 indexed citations
8.
Finlay, A.Y., Allen P. Kaplan, Lisa A. Beck, et al.. (2017). Omalizumab substantially improves dermatology‐related quality of life in patients with chronic spontaneous urticaria. Journal of the European Academy of Dermatology and Venereology. 31(10). 1715–1721. 35 indexed citations
9.
McBride, David, et al.. (2016). Assure-Csu: Resource Use and Economic Burden in Patients with Refractory Chronic Spontaneous/Idiopathic Urticaria in Italy. Value in Health. 19(7). A614–A614. 1 indexed citations
10.
Balp, M.M., Mohamed Abuzakouk, F. Bérard, et al.. (2016). Comparison of Direct Healthcare Costs Associated with Chronic Spontaneous /Idiopathic Urticaria in 7 Countries - Results from the Assure-CSU Study. Value in Health. 19(7). A565–A565. 2 indexed citations
11.
McBride, Doreen, Mohamed Abuzakouk, M.M. Balp, et al.. (2016). Comparative Analysis of Indirect Costs Associated with Chronic Spontaneous/Idiopathic Urticaria-Results From The Assure-Csu Study In 7 Countries. Value in Health. 19(7). A573–A573. 1 indexed citations
12.
McBride, Doreen, M.M. Balp, Mohamed Abuzakouk, et al.. (2016). Assure-Csu: Assessing the Impact of Chronic Spontaneous / Idiopathic Urticaria on Work Productivity and Activity. Value in Health. 19(3). A124–A125. 1 indexed citations
13.
Sussman, Gordon, Susan Waserman, Paul K. Keith, et al.. (2015). Assure-Csu Canadian Results: Assessing Health Utility In Chronic Spontaneous/Idiopathic Urticaria Using The Eq-5d. Value in Health. 18(3). A175–A175. 1 indexed citations
14.
15.
Graham, James E., et al.. (2015). Cost-Utility of Omalizumab Compared With Standard of Care for The Treatment of Chronic Spontaneous Urticaria (Csu). Value in Health. 18(7). A423–A423. 1 indexed citations
16.
Hawe, Emma, Donald E. Stull, Doreen McBride, & M.M. Balp. (2014). Estimating Utility Data for Patient Symptom Severity in Chronic Spontaneous Urticaria. Value in Health. 17(7). A610–A611. 1 indexed citations
17.
Janssen, K, K Higashi, Jos C. Jansen, et al.. (2013). Efficacy of Inhaled Antibiotics in CF Patients with Chronic P. Aeruginosa Infection: A Network Meta-Analysis. Value in Health. 16(7). A619–A619. 1 indexed citations
18.
19.
Overbeek, Jetty A., et al.. (2012). PRS8 Burden of Exacerbations in Patients With COPD in the Netherlands: a Real-Life Study. Value in Health. 15(7). A560–A561. 1 indexed citations
20.
Zimovetz, Evelina A., et al.. (2012). PRS18 Systematic Review of Economic Evaluations, Utility Estimates, Resource Utilisation, and Costs in Chronic Idiopathic Urticaria. Value in Health. 15(7). A562–A562. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christof Pohl Breakdown of academic impact, for papers by Maximiliano Gómez Breakdown of academic impact, for papers by Warner Carr Breakdown of academic impact, for papers by María Jesús Castillo Breakdown of academic impact, for papers by Anushya Jeyabalan Breakdown of academic impact, for papers by Neil L. Kao Breakdown of academic impact, for papers by Elaine Smith Breakdown of academic impact, for papers by Sílvia Papasidero Breakdown of academic impact, for papers by Domenico Olivo Breakdown of academic impact, for papers by Jolanta Gąsior
Rankless by CCL
2026